Garzulys
Insulin aspart-fsan · Meitheal Pharmaceuticals Inc.
PRESCRIPTION ONLY (USA)Garzulys ingredients
| Active ingredient | Strength |
|---|---|
| Insulin Aspart | 100 [iU]/mL |
What Garzulys is used for
Garzulys is a specialist medicine (insulin analog). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Garzulys
- Generic name
- Insulin aspart-fsan
- Made by
- Meitheal Pharmaceuticals Inc.
- Forms
- Injection, Solution
- Given
- Intravenous, Subcutaneous
- Drug class
- Insulin Analog
- FDA approval
- Biologic licence (BLA) BLA761497
- On the US market since
- 2026
Official information
- Garzulys prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Insulin aspart-fsan)
In India
- Insulin aspart: 12 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Garzulys?
Garzulys (Insulin aspart-fsan) is a specialist medicine made by Meitheal Pharmaceuticals Inc., approved by the US FDA.
What are the ingredients of Garzulys?
Garzulys contains Insulin Aspart (100 [iU]/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA